Reviews on New Drug Targets in Age-Related Disorders

Dr. Paul C. Guest, Ph.D, is a scientific researcher/writer with 37 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and age-related diseases such as diabetes, cancer, cardiovascular disorders, sarcopenia and Alzheimer’s disease.

• Ch-01 Targeting ROS-mediated Crosstalk between Autophagy and Apoptosis in Cancer.- Ch-02 Micronutrients that Affect Immunosenescence.- Ch-03 Bioactive Lipids in Age-Related Disorders.- Ch-04 Effect of Short Chain Fatty Acids on Age-Related Disorders.- Ch-05 The Effects of Parabiosis on Aging and Age-related Diseases.- Ch-06 Skeletal Muscle Aging Atrophy: Assessment and Exercise-Based Treatment.- Ch-07 Polyphenols as an Effective Therapeutic Intervention Against Cognitive Decline during Normal and Pathological Brain Aging.- Ch-08 Early Diagnosis and Targeted Treatment Strategy for Improved Therapeutic Outcomes in Alzheimer’s Disease.- Ch-09 Resetting the Aging Clock: Implications for Managing Age-Related Diseases.- Ch-10 The Challenge of Antidepressant Therapeutics in Alzheimer's Disease.- Ch-11 Anxiolytic Terpenoids and Aromatherapy for Anxiety and Depression.- Ch-12 The Role of Nutrition in Attenuating Age-Related Skeletal Muscle Atrophy.- Ch-13 The Use of Metformin to Increase the Human Healthspan